Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Teva Pharmaceutical Industries Ltd.
Current Parent Company: Teva Pharmaceutical Industries
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $69,000,000
Year: 2019
Date: July 29, 2019
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Secondary Offense: generic drug pay for delay
Mega-Scandal: Generic Drug Pay for Delay
Violation Description: The state had accused Teva of entering collusive agreements to delay the introduction of lower-cost substitutes for its narcolepsy drug Provigil.
Level of Government: state
Action Type: agency action
Agency: California Attorney General
Civil or Criminal Case: civil
Facility State: California
HQ Country of Current Parent: Israel
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.